Neurodegenerative Disease Technologies

Antibody based reagents that specifically recognize toxic oligomeric forms of beta-amyloid

Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments

Compounds to Modulate Retinoid X Receptors

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury